Vaccine News and Research

Latest Vaccine News and Research

Study determines hemagglutinin inhibition seroprevalence against swine influenza viruses circulating in Hong Kong and Guangzhou

Researchers performed a quantitative assessment of the age-stratified seroprevalence of hemagglutination inhibition antibodies against five swine influenza viruses circulating in the Guangzhou and Hong Kong cities of China.

13 Apr 2022

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

A new study has stated that the third booster dose of mRNA-based COVID-19 vaccines is 68% effective in preventing reinfection-related hospitalization among persons with a history of SARS-CoV-2.

13 Apr 2022

Study explores myopericarditis incidence and COVID-19 vaccination

Researchers investigated the impact of COVID-19 vaccination on the incidence of myopericarditis.

13 Apr 2022

Impact of COVID-19 infection and vaccination on antibody response

A new study assessed the impact of COVID-19 and vaccination on antibody responses.

13 Apr 2022

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Researchers examined the risk of breakthrough COVID-19 infections, hospitalizations, and mortality among COVID-19-vaccinated cancer patients.

13 Apr 2022

Study finds a consistent temporal association between mask use and COVID-19 vaccination status

In a recent study, both vaccinated and unvaccinated participants from the COVID-19 Community Research Partnership (CRP) had their mask-wearing habits evaluated.

13 Apr 2022

Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

The overall risk of myopericarditis following COVID-19 vaccination is very low, affecting 18 people per million vaccine doses. A new study published in The Lancet Respiratory Medicine, confirms that this risk is comparable to or lower following COVID-19 vaccination than other non-COVID-19 vaccines.

13 Apr 2022

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

A recent study assessed the efficacy of the second and third doses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccines against the SARS-CoV-2 Omicron and Delta variants in outpatient settings.

13 Apr 2022

mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

In a recent study under consideration at Nature Portfolio Journal and posted to the Research Square* preprint server, researchers characterized severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S)-specific cluster of differentiation 8 (CD8+) T cell responses.

12 Apr 2022

Antibody response following Omicron BA.2 infection is lower than BA.1

In a recent report posted to the medRxiv* preprint server, researchers determined immune responses generated by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2 and BA.1 sublineage infections in prior virus-infected and naïve subjects.

12 Apr 2022

Does COVID-19 vaccination affect IVF treatments?

A new study assesses the impact of COVID-19 vaccination in women undergoing assisted reproduction.

12 Apr 2022

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR Annual Meeting 2022, held April 8-13.

12 Apr 2022

Parallel approach to vaccine trials can lead to faster and more accurate assessment

Some of Rutgers' top health researchers are calling for a change in our approach to developing COVID-19 vaccines, and vaccines to fight future pandemics, to incorporate both conventional and challenge trails.

12 Apr 2022

Injection-free dermally delivered subunit vaccine strongly neutralizes SARS-CoV-2 variants

Researchers in Australia have evaluated the vaccine candidature of HexaPro S protein subunit vaccine against SARS-CoV-2.

12 Apr 2022

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

In a new study, researchers quantified the serological responses following the third dose of mRNA-based COVID-19 vaccines in patients with hematological malignancies.

12 Apr 2022

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Heart complications are uncommon, yet treatable for children and young adults after COVID-19 disease or SARS-CoV-2 infection, according to a new scientific statement from the American Heart Association that details what has been learned about how to treat, manage and even prevent cardiovascular complications from the SARS-CoV-2 virus in youth.

12 Apr 2022

Early COVID-19 reinfections possible within 60 days of initial infection

Researchers reported that COVID-19 reinfections could occur within 60 days of the initial infection.

12 Apr 2022

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

A recent study published in PLoS ONE assessed the association of the prevalence of the COVID-19 pandemic with vaccine efficacy.

12 Apr 2022

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

A new study assessed the effectiveness of the BNT162b2 SARS-CoV-2 vaccine against Delta and Omicron variants in adolescents.

12 Apr 2022

Insight into the Breast Cancer Landscape with Breast Cancer Now

In this interview, we speak with Dr. Simon Vincent, Director of Research, Support, and Influencing at Breast Cancer Now, about the current landscape of breast cancer.

12 Apr 2022

Vaccine News and Research

Latest Vaccine News and Research

Study determines hemagglutinin inhibition seroprevalence against swine influenza viruses circulating in Hong Kong and Guangzhou

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

Study explores myopericarditis incidence and COVID-19 vaccination

Impact of COVID-19 infection and vaccination on antibody response

High risk of COVID-19 breakthrough infections among vaccinated individuals with cancer

Study finds a consistent temporal association between mask use and COVID-19 vaccination status

Risk of myopericarditis following COVID-19 vaccination is very low, confirms study

Research shows effectiveness of a 3rd mRNA COVID-19 vaccine dose

mRNA vaccines induce CD8+ T cells that may reduce COVID-19 severity

Antibody response following Omicron BA.2 infection is lower than BA.1

Does COVID-19 vaccination affect IVF treatments?

New COVID-19 vaccine induces T-cell immune responses in most patients with B-cell deficiencies

Parallel approach to vaccine trials can lead to faster and more accurate assessment

Injection-free dermally delivered subunit vaccine strongly neutralizes SARS-CoV-2 variants

Third dose of messenger RNA vaccines found to increase serological immunity in hematological malignancy patients

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Early COVID-19 reinfections possible within 60 days of initial infection

Study finds efficacy of SARS-CoV-2 vaccines reported in Phase 3 trials declines as pandemic prevalence at trial sites increases

Exploring vaccine effectiveness against SARS-CoV-2 Omicron and Delta variants in adolescents

Insight into the Breast Cancer Landscape with Breast Cancer Now

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in